Evolus Inc Stock Annual Yield

EOLS Stock

USD 16.50 0.01 0.06%

Evolus Inc fundamentals help investors to digest information that contributes to Evolus' financial success or failures. It also enables traders to predict the movement of Evolus Stock. The fundamental analysis module provides a way to measure Evolus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evolus stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Evolus Inc Company Annual Yield Analysis

Evolus' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Evolus Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Evolus is extremely important. It helps to project a fair market value of Evolus Stock properly, considering its historical fundamentals such as Annual Yield. Since Evolus' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Evolus' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Evolus' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Good Will	Short Term Investments	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Capital Surpluse	Net Receivables	Net Invested Capital	Net Working Capital	Long Term Debt	Capital Stock	Common Stock	Long Term Debt Total	Property Plant Equipment	Current Deferred Revenue
Total Assets		-0.77	0.3	-0.36	-0.76	0.43	-0.27	0.61	0.77	-0.93	0.55	1.0	-0.25	-0.39	0.85	-0.91	-0.22	0.89	0.75	-0.27	-0.27	-0.65	-0.63	0.53
Total Stockholder Equity	-0.77		-0.13	0.43	0.36	-0.09	-0.15	-0.14	-0.61	0.59	-0.29	-0.77	0.01	-0.04	-0.44	0.67	0.07	-0.53	-0.3	-0.15	-0.15	0.34	0.32	-0.06
Net Tangible Assets	0.3	-0.13		-0.82	-0.13	0.06	-0.01	0.29	-0.37	-0.15	-0.32	0.3	-0.82	-0.08	0.22	-0.4	0.37	0.63	0.32	-0.01	-0.01	0.0	-0.33	0.24
Net Debt	-0.36	0.43	-0.82		0.19	-0.17	-0.16	-0.14	0.21	0.18	0.45	-0.37	0.79	-0.01	-0.19	0.57	-0.03	-0.6	-0.2	-0.16	-0.16	0.11	0.27	-0.11
Retained Earnings	-0.76	0.36	-0.13	0.19		-0.64	0.62	-0.91	-0.7	0.77	-0.37	-0.76	0.41	0.84	-0.9	0.76	0.55	-0.74	-0.86	0.62	0.62	0.97	0.86	-0.89
Accounts Payable	0.43	-0.09	0.06	-0.17	-0.64		-0.08	0.55	0.38	-0.5	0.17	0.44	-0.29	-0.48	0.59	-0.51	-0.47	0.46	0.46	-0.08	-0.08	-0.54	-0.52	0.55
Good Will	-0.27	-0.15	-0.01	-0.16	0.62	-0.08		-0.69	-0.3	0.35	-0.25	-0.25	0.29	0.81	-0.4	0.29	0.38	-0.32	-0.54	1.0	1.0	0.68	0.49	-0.63
Short Term Investments	0.61	-0.14	0.29	-0.14	-0.91	0.55	-0.69		0.46	-0.64	0.35	0.61	-0.46	-0.93	0.85	-0.56	-0.34	0.68	0.8	-0.69	-0.69	-0.88	-0.95	0.97
Total Liab	0.77	-0.61	-0.37	0.21	-0.7	0.38	-0.3	0.46		-0.81	0.74	0.77	0.26	-0.39	0.74	-0.62	-0.49	0.46	0.58	-0.3	-0.3	-0.68	-0.45	0.44
Deferred Long Term Liab	-0.93	0.59	-0.15	0.18	0.77	-0.5	0.35	-0.64	-0.81		-0.72	-0.93	0.13	0.48	-0.9	0.88	0.42	-0.84	-0.7	0.35	0.35	0.66	0.58	-0.56
Short Long Term Debt	0.55	-0.29	-0.32	0.45	-0.37	0.17	-0.25	0.35	0.74	-0.72		0.55	0.51	-0.27	0.59	-0.33	-0.19	0.32	0.31	-0.25	-0.25	-0.31	-0.26	0.28
Total Current Assets	1.0	-0.77	0.3	-0.37	-0.76	0.44	-0.25	0.61	0.77	-0.93	0.55		-0.25	-0.39	0.86	-0.91	-0.23	0.89	0.75	-0.25	-0.25	-0.65	-0.65	0.54
Short Term Debt	-0.25	0.01	-0.82	0.79	0.41	-0.29	0.29	-0.46	0.26	0.13	0.51	-0.25		0.37	-0.28	0.47	0.03	-0.6	-0.5	0.29	0.29	0.34	0.46	-0.47
Intangible Assets	-0.39	-0.04	-0.08	-0.01	0.84	-0.48	0.81	-0.93	-0.39	0.48	-0.27	-0.39	0.37		-0.68	0.4	0.52	-0.45	-0.62	0.81	0.81	0.89	0.84	-0.91
Capital Surpluse	0.85	-0.44	0.22	-0.19	-0.9	0.59	-0.4	0.85	0.74	-0.9	0.59	0.86	-0.28	-0.68		-0.78	-0.4	0.82	0.84	-0.4	-0.4	-0.81	-0.83	0.84
Net Receivables	-0.91	0.67	-0.4	0.57	0.76	-0.51	0.29	-0.56	-0.62	0.88	-0.33	-0.91	0.47	0.4	-0.78		0.43	-0.92	-0.69	0.29	0.29	0.65	0.55	-0.49
Net Invested Capital	-0.22	0.07	0.37	-0.03	0.55	-0.47	0.38	-0.34	-0.49	0.42	-0.19	-0.23	0.03	0.52	-0.4	0.43		-0.16	-0.18	0.38	0.38	0.62	0.24	-0.37
Net Working Capital	0.89	-0.53	0.63	-0.6	-0.74	0.46	-0.32	0.68	0.46	-0.84	0.32	0.89	-0.6	-0.45	0.82	-0.92	-0.16		0.79	-0.32	-0.32	-0.58	-0.66	0.61
Long Term Debt	0.75	-0.3	0.32	-0.2	-0.86	0.46	-0.54	0.8	0.58	-0.7	0.31	0.75	-0.5	-0.62	0.84	-0.69	-0.18	0.79		-0.54	-0.54	-0.76	-0.75	0.82
Capital Stock	-0.27	-0.15	-0.01	-0.16	0.62	-0.08	1.0	-0.69	-0.3	0.35	-0.25	-0.25	0.29	0.81	-0.4	0.29	0.38	-0.32	-0.54		1.0	0.68	0.49	-0.63
Common Stock	-0.27	-0.15	-0.01	-0.16	0.62	-0.08	1.0	-0.69	-0.3	0.35	-0.25	-0.25	0.29	0.81	-0.4	0.29	0.38	-0.32	-0.54	1.0		0.68	0.49	-0.63
Long Term Debt Total	-0.65	0.34	0.0	0.11	0.97	-0.54	0.68	-0.88	-0.68	0.66	-0.31	-0.65	0.34	0.89	-0.81	0.65	0.62	-0.58	-0.76	0.68	0.68		0.85	-0.87
Property Plant Equipment	-0.63	0.32	-0.33	0.27	0.86	-0.52	0.49	-0.95	-0.45	0.58	-0.26	-0.65	0.46	0.84	-0.83	0.55	0.24	-0.66	-0.75	0.49	0.49	0.85		-0.93
Current Deferred Revenue	0.53	-0.06	0.24	-0.11	-0.89	0.55	-0.63	0.97	0.44	-0.56	0.28	0.54	-0.47	-0.91	0.84	-0.49	-0.37	0.61	0.82	-0.63	-0.63	-0.87	-0.93

Click cells to compare fundamentals

Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.

Competition

Predict Evolus

In accordance with the recently published financial statements, Evolus Inc has an Annual Yield of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Evolus Current Valuation Drivers

We derive many important indicators used in calculating different scores of Evolus from analyzing Evolus' financial statements. These drivers represent accounts that assess Evolus' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Evolus' important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	343.7M	113.4M	324.0M	421.1M	599.4M	629.3M
Enterprise Value	330.3M	149.1M	252.5M	440.3M	663.1M	696.2M

Evolus ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Evolus' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Evolus' managers, analysts, and investors.

Environmental

Governance

Social

Evolus Fundamentals

	Return On Equity	-8.62
	Return On Asset	-0.0936
	Profit Margin	(0.22) %
	Operating Margin	(0.09) %
	Current Valuation	1.07 B
	Shares Outstanding	63.09 M
	Shares Owned By Insiders	12.30 %
	Shares Owned By Institutions	82.21 %
	Number Of Shares Shorted	4.88 M
	Price To Earning	(5.55) X
	Price To Book	53.90 X
	Price To Sales	4.39 X
	Revenue	202.09 M
	Gross Profit	92.73 M
	EBITDA	(30.24 M)
	Net Income	(61.69 M)
	Cash And Equivalents	84.48 M
	Cash Per Share	1.51 X
	Total Debt	126.55 M
	Debt To Equity	1.59 %
	Current Ratio	2.60 X
	Book Value Per Share	0.31 X
	Cash Flow From Operations	(34.01 M)
	Short Ratio	8.26 X
	Earnings Per Share	(0.90) X
	Price To Earnings To Growth	(0.52) X
	Target Price	23.43
	Number Of Employees	304
	Beta	1.31
	Market Capitalization	1.04 B
	Total Asset	189 M
	Retained Earnings	(558.98 M)
	Working Capital	64.13 M
	Current Asset	27.24 M
	Current Liabilities	76.8 M
	Net Asset	189 M

About Evolus Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Evolus Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evolus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evolus Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC